IRVINE, Calif., Oct. 1, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Charles Love to the position Vice President of Clinical Affairs. Mr. Love will be responsible for overseeing all Endologix U.S. and international clinical trials and will report to John McDermott, President and Chief Executive Officer. Janet Fauls, previously Vice President of Regulatory and Clinical Affairs, will maintain responsibility for overseeing Regulatory Affairs as the Company prepares for multiple upcoming potential regulatory milestones for its product pipeline.
Endologix Appoints Charles Love Vice President Of Clinical Affairs
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.